# Oxford Biomedica (UK) Limited – FDA Inspection, Feb 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/oxford-biomedica-uk-limited/22310181-9aa0-4704-a6f6-4665f2faa926
Source feed: FDA_Inspections

> FDA inspection 1082991 of Oxford Biomedica (UK) Limited, February 20, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082991
- Company Name: Oxford Biomedica (UK) Limited
- Inspection Date: 2019-02-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1245331 - 2024-06-17
- [FDA Inspection 1020060 - 2017-05-24](https://www.keypedia.com/records/fda_inspections/oxford-biomedica-uk-limited/9456d763-8ef7-4fc9-ab96-16a12218017d)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)

Company: https://www.keypedia.com/companies/oxford-biomedica-uk-limited/12d29c20-d7d1-4ab9-830f-5d9f25a506ad

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d